Astegolimab

• CAT Number: I042171
• CAS Number: 2173054-79-8
• Purity: ≥95%

Astegolimab（Cat No.:I042171）is an investigational monoclonal antibody that targets and inhibits the receptor ST2 (also known as IL-33 receptor), which plays a role in regulating immune responses and inflammation. ST2 is involved in various inflammatory and autoimmune conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis. By blocking ST2, astegolimab aims to reduce inflammation and improve symptoms in these diseases. It is being studied in clinical trials to evaluate its safety, efficacy, and potential to treat a variety of chronic inflammatory conditions, offering a new approach to managing immune-mediated diseases.